MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with R

Rizatriptan

Rizatriptan 5mg orodispersible tablets sugar free

No stability information

Stability notes for Rizatriptan 5mg orodispersible tablets sugar free

There are no stability notes for this medicine.

Suppliers

Rizatriptan 5mg orodispersible tablets sugar free (Alliance Healthcare (Distribution) Ltd)
Rizatriptan 5mg orodispersible tablets sugar free (Aspire Pharma Ltd)
Rizatriptan 5mg orodispersible tablets sugar free (Macleods Pharma UK Ltd)

Rizatriptan 5mg tablets

Compatible

Stability notes for Rizatriptan 5mg tablets

No special requirements for storage.

Provenance

This compatibility recommendation is derived from Maxalt 5mg tablets (Organon Pharma (UK) Ltd).

Suppliers (7) of Rizatriptan 5mg tablets
Maxalt 5mg tablets (CST Pharma Ltd)
Maxalt 5mg tablets (Organon Pharma (UK) Ltd)
Rizatriptan 5mg tablets (A A H Pharmaceuticals Ltd)
Rizatriptan 5mg tablets (Alliance Healthcare (Distribution) Ltd)
Rizatriptan 5mg tablets (Aspire Pharma Ltd)
Rizatriptan 5mg tablets (Glenmark Pharmaceuticals Europe Ltd)
Rizatriptan 5mg tablets (Medihealth (Northern) Ltd)

Rizatriptan 10mg oral lyophilisates sugar free

Incompatible

Stability notes for Rizatriptan 10mg oral lyophilisates sugar free

Unsuitable for MCA as hygroscopic.

Provenance

This compatibility recommendation is derived from Maxalt Melt 10mg oral lyophilisates (Organon Pharma (UK) Ltd).

Suppliers (4) of Rizatriptan 10mg oral lyophilisates sugar free
Maxalt Melt 10mg oral lyophilisates (Lexon (UK) Ltd)
Maxalt Melt 10mg oral lyophilisates (Organon Pharma (UK) Ltd)
Maxalt Melt 10mg oral lyophilisates (Pilsco Ltd)
Maxalt Melt 10mg oral lyophilisates (Sigma Pharmaceuticals Plc)

Rizatriptan 10mg orodispersible tablets sugar free

No stability information

Stability notes for Rizatriptan 10mg orodispersible tablets sugar free

There are no stability notes for this medicine.

Suppliers (11) of Rizatriptan 10mg orodispersible tablets sugar free
Rizatriptan 10mg orodispersible tablets sugar free (A A H Pharmaceuticals Ltd)
Rizatriptan 10mg orodispersible tablets sugar free (Accord-UK Ltd)
Rizatriptan 10mg orodispersible tablets sugar free (Alliance Healthcare (Distribution) Ltd)
Rizatriptan 10mg orodispersible tablets sugar free (Aspire Pharma Ltd)
Rizatriptan 10mg orodispersible tablets sugar free (Glenmark Pharmaceuticals Europe Ltd)
Rizatriptan 10mg orodispersible tablets sugar free (Macleods Pharma UK Ltd)
Rizatriptan 10mg orodispersible tablets sugar free (Medihealth (Northern) Ltd)
Rizatriptan 10mg orodispersible tablets sugar free (Milpharm Ltd)
Rizatriptan 10mg orodispersible tablets sugar free (Necessity Supplies Ltd)
Rizatriptan 10mg orodispersible tablets sugar free (Neuraxpharm UK Ltd)
Rizatriptan 10mg orodispersible tablets sugar free (Tillomed Laboratories Ltd)

Rizatriptan 10mg tablets

Compatible

Stability notes for Rizatriptan 10mg tablets

No special requirements for storage.

Provenance

This compatibility recommendation is derived from Maxalt 10mg tablets (Organon Pharma (UK) Ltd).

Suppliers (11) of Rizatriptan 10mg tablets
Maxalt 10mg tablets (CST Pharma Ltd)
Maxalt 10mg tablets (Organon Pharma (UK) Ltd)
Maxalt 10mg tablets (Sigma Pharmaceuticals Plc)
Rizatriptan 10mg tablets (A A H Pharmaceuticals Ltd)
Rizatriptan 10mg tablets (Alliance Healthcare (Distribution) Ltd)
Rizatriptan 10mg tablets (Aspire Pharma Ltd)
Rizatriptan 10mg tablets (Glenmark Pharmaceuticals Europe Ltd)
Rizatriptan 10mg tablets (Medihealth (Northern) Ltd)
Rizatriptan 10mg tablets (Milpharm Ltd)
Rizatriptan 10mg tablets (Necessity Supplies Ltd)
Rizatriptan 10mg tablets (Tillomed Laboratories Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.